Latest Asx News

Terra Critical Minerals (ASX, T92) broadens its critical minerals portfolio with new US initiatives and promising exploration in New South Wales and Canada. The company also pursues a US OTC listing to tap North American capital.

Vulcan Steel reported a sharp profit decline in FY25 amid tough market conditions but strengthened its balance sheet and expanded into roofing with a major acquisition. Leadership changes set the stage for renewed growth.

HALO Technologies reports a 17% rise in quarterly revenue, driven by a surge in brokerage income and a strategic launch of Managed Funds in Australia, supported by a recent $3.9 million rights issue.

Pure Hydrogen Corporation reported strong commercial momentum in the September 2025 quarter, securing multiple hydrogen vehicle orders across Australia and the US, expanding international distribution, and raising fresh capital to fuel growth.

HITIQ Ltd has secured a landmark order for its PROTEQT™ mouthguards at the Winter Olympics and launched in the UK consumer market, while advancing global validation and raising over A$2 million in capital.

International Graphite Limited has made significant strides in its global graphite strategy, signing a German joint venture and securing $3 million in US institutional funding to support its expanding mine-to-market operations.

Income Asset Management has issued 34 million new equity-linked securities to key staff, potentially diluting shares by 3.7%, aiming to better align employee rewards with shareholder value.

Auravelle Metals reports exceptional high-grade gold results from its initial drilling at South Australia's Nuckulla Hill Project, alongside ongoing exploration efforts in Western Australia and a successful capital raise.

Cobram Estate Olives Limited has reported a record-breaking FY2025, driven by strong sales growth in Australia and the USA, alongside a $178 million equity raise to accelerate its Californian olive grove expansion.

Australian Pacific Coal’s Dartbrook Mine has entered voluntary administration and receivership, with the company’s interest now considered to hold no value amid mounting secured debt pressures. Despite this, the company remains solvent with limited cash reserves and continues to assess its next steps.

The Treasurer has expressed preliminary concerns that Cosette Pharmaceuticals’ proposed acquisition of Mayne Pharma could harm Australia’s economy, citing plans to close a key Adelaide manufacturing site. Mayne Pharma disputes these claims and urges a resolution before the scheme deadline.

Mad Paws Holdings reported a robust September quarter with 14% revenue growth and a successful divestment of Pet Chemist, while advancing its acquisition scheme with Rover Group.